CLS3474
Corning® Costar® Ultra-Low Attachment Multiple Well Plate
size 96 well, flat bottom clear, pkg of (individually wrapped), pkg of (24/case), sterile, lid
동의어(들):
96 multiwell plate, 96 well microplate, 96 well microtiter plate, 96 well plate, cell culture plate, tissue culture plate
로그인조직 및 계약 가격 보기
모든 사진(1)
About This Item
UNSPSC 코드:
41121800
NACRES:
NB.13
추천 제품
material
clear
flat bottom clear
polystyrene
round wells
무균
sterile
sterile
특징
lid
lid
skirt
plate format: standard
well: flat bottom, clear
포장
pack of 1 (individually wrapped w/ lid)
case of 24
pkg of (24/case)
pkg of (individually wrapped)
제조업체/상표
Corning 3474
크기
96 well
표면적
0.32 cm2 , cell growth area (cm2)
웰 용적
360 μL
웰 작업 용적
75-200 μL
웰
96 wells
색상
clear
결합 유형
(Ultra-Low Attachment)
유사한 제품을 찾으십니까? 방문 제품 비교 안내
일반 설명
Corning Costar Ultra-Low Attachment Multiwell Plates
- Ultra-Low attachment plates feature a covalently bound hydrogel layer that effectively inhibits cellular attachment
- Surface minimizes protein absorption, enzyme activation, and cellular activation
- Surface is non-cytotoxic, biologically inert, and nondegradable
- Nonreversible lids with condensation rings to reduce contamination
- Individual alphanumerical codes for well identification
- Uniform footprint for ease in stacking
- Sterilized by gamma irradiation and certified nonpyrogenic
법적 정보
Corning is a registered trademark of Corning, Inc.
Costar is a registered trademark of Corning, Inc.
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
이미 열람한 고객
Haitang Yang et al.
Cancers, 12(8) (2020-08-23)
Background: Malignant pleural mesothelioma (MPM) is driven by the inactivation of tumor suppressor genes (TSGs). An unmet need in the field is the translation of the genomic landscape into effective TSG-specific therapies. Methods: We correlated genomes against transcriptomes of patients'
Gianpaolo Zarletti et al.
Viruses, 12(11) (2020-11-12)
Knowledge of the antibody-mediated immune response to SARS-CoV-2 is crucial to understand virus immunogenicity, establish seroprevalence, and determine whether subjects or recovered patients are at risk for infection/reinfection and would therefore benefit from vaccination. Here, we describe a novel and
Shiny Amala Priya Rajan et al.
Acta biomaterialia, 106, 124-135 (2020-02-19)
Current drug development techniques are expensive and inefficient, partially due to the use of preclinical models that do not accurately recapitulate in vivo drug efficacy and cytotoxicity. To address this challenge, we report on an integrated, in vitro multi-organoid system
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.